Mobile Site ›
Bleeding and Thrombosing Diseases Conference

15th Bleeding and Thrombosing Diseases Conference


August 7-9, 2013
Kahler Grand Hotel
Rochester, Minnesota

Presented By

  • Mayo Clinic Division of Hematology, Department of Internal Medicine; and the Division of Hematopathology, Department of Laboratory Medicine and Pathology
  • Mayo Medical Laboratories

Conference Description

This Mayo Clinic conference will provide reviews and updates about laboratory and clinical aspects of bleeding and thrombosing disorders. Didactic presentations will be supplemented with panel discussions and case presentations. Adequate time will be allocated for questions.

Conference Objectives

Upon completion of the conference, participants should be able to:

  • Describe recommended clinical and laboratory evaluation for von Willebrand disease (VWD)
  • Assess common acquired disorders of plasmatic hemostasis that lead to bleeding or thrombosis
  • Recognize features of hereditary platelet disorders
  • Evaluate antibody-mediated prothrombotic disorders such as heparin-induced thrombocytopenia, thrombotic thrombocytopenic purpura, or lupus anticoagulant and antiphospholipid syndrome
  • Summarize clinical features and laboratory evaluation of congenital and acquired bleeding disorders
  • Discuss updates in venous thromboembolism and features of newer anticoagulant drugs

Intended Audience

This program is designed for clinicians, pathologists, scientists, and laboratory technologists whose practices include bleeding and thrombosing diseases

Disclaimer

Attendance at this Mayo conference does not indicate nor guarantee competence or proficiency in the performance of any procedures that may be discussed or taught in this course.


Key